Renal involvement in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL)

Clinical Nephrology

Volumn 67, Issue 3, 2007, Pages 182-187

  Kusaba, T ^a   Hatta, T ^a   Kimura, T ^a   Sonomura, K ^a   Tanda, S ^a   Kishimoto, N ^a   Kameyama, H ^a   Okigaki, M ^a   Mori, Y ^a   Ishigami, N ^a   Mizuno, T ^a   Nakagawa, M ^a   Matsubara, H ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL); Granular osmophilic material (GOM); Notch3 mutation; Renal biopsy

Indexed keywords

IMMUNOGLOBULIN A; NOTCH3 RECEPTOR;

ADULT; ANAMNESIS; ARTICLE; BLOOD EXAMINATION; CADASIL; CASE REPORT; DISEASE SEVERITY; ELECTRON MICROSCOPY; FEMALE; HEMATURIA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOGLOBULIN A NEPHROPATHY; IMMUNOHISTOLOGY; KIDNEY FAILURE; MISSENSE MUTATION; NUCLEAR MAGNETIC RESONANCE IMAGING; URINALYSIS;

EID: 33947271015     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: 10.5414/CNP67182     Document Type: Article

References (23)

1. Bergmann M, Ebke M et al. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL): a morphological study of a German family. Acta Neuropathol. 1996; 92: 341-350.
2. Brulin P, Godfraind C et al. Morphometric analysis of ultrastructural vascular changes in CADASIL: analysis of 50 skin biopsy specimens and pathogenic implications. Acta Neuropathol. 2002; 104: 241-248.
3. Campos AH, Wang W et al. Determinants of Notch-3 receptor expression and signaling in vascular smooth muscle cells: implications in cell-cycle regulation. Circ Res. 2002; 91: 999-1006.
4. Davous P. CADASIL: a review with proposed diagnostic criteria. Eur J Neurol. 1998; 5: 219-233.
5. Desmond DW, Moroney JT et al. The natural history of CADASIL: a pooled analysis of previously published cases. Stroke. 1999; 30: 1230-1233.
6. Hussain MB, Singhal S et al. Abnormal vasoconstrictor responses to angiotensin II and noradrenaline in isolated small arteries from patients with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL). Stroke. 2004; 35: 853-858.
7. Ishiko A, Shimizu A et al. Notch3 ectodomain is a major component of granular osmiophilic material (GOM) in CADASIL. Acta Neuropathol. 2006; 112: 333-339.
8. Joutel A, Andreux F et al. The ectodomain of the Notch3 receptor accumulates within the cerebrovasculature of CADASIL patients. J Clin Invest. 2000; 105: 597-605.
9. Joutel A, Corpechot C et al. Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia. Nature. 1996; 383: 707-710.
10. Joutel A, Favrole P et al. Skin biopsy immunostaining with a Notch3 monoclonal antibody for CADASIL diagnosis. Lancet. 2001; 358: 2049-2051.
11. Joutel A, Vahedi K et al. Strong clustering and stereo-typed nature of Notch3 mutations in CADASIL patients. Lancet. 1997; 350: 1511-1515.
12. Kanitakis J, Thobois S et al. CADASIL (cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy): a neurovascular disease diagnosed by ultrastructural examination of the skin. J Cutan Pathol. 2002; 29: 498-501.
13. Manabe Y, Murakami T et al. Nocturnal blood pressure dip in CADASIL. J Neurol Sci. 2001; 193: 13-16.
14. Ohishi K, Varnum-Finney B et al. Monocytes express high amounts of Notch and undergo cytokine specific apoptosis following interaction with the Notch ligand, Delta-1. Blood. 2000; 95: 2847-2854.
15. Okeda R, Arima K et al. Arterial changes in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) in relation to pathogenesis of diffuse myelin loss of cerebral white matter: examination of cerebral medullary arteries by reconstruction of serial sections of an autopsy case. Stroke. 2002; 33: 2565-2569.
16. Peters N, Herzog J et al. A two-year clinical follow-up study in 80 CADASIL subjects: progression patterns and implications for clinical trials. Stroke. 2004; 35: 1603-1608.
17. Pfefferkorn T, von Stuckrad-Barre S et al. Reduced cerebrovascular CO(2) reactivity in CADASIL: A transcranial Doppler sonography study. Stroke. 2001; 32: 17-21.
18. Ruchoux MM, Guerouaou D et al. Systemic vascular smooth muscle cell impairment in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. Acta Neuropathol. 1995; 89: 500-512.
19. Santa Y, Uyama E et al. Genetic, clinical and pathological studies of CADASIL in Japan: a partial contribution of Notch3 mutations and implications of smooth muscle cell degeneration for the pathogenesis. J Neurol Sci. 2003; 212: 79-84.
20. Sestan N, Artavanis-Tsakonas S et al. Contact-dependent inhibition of cortical neurite growth mediated by Notch signaling. Science. 1999; 286: 741-746.
21. Spinner NB. CADASIL: Notch signaling defect or protein accumulation problem? J Clin Invest. 2000; 105: 561-562.
22. Tournier-Lasserve E, Joutel A et al. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy maps to chromosome 19q12. Nat Genet. 1993; 3: 256-259.
23. Walsh JS, Perniciaro C et al. CADASIL (cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy): diagnostic skin biopsy changes determined by electron microscopy. J Am Acad Dermatol. 2000; 43: 1125-1127.